In fact, antibody responses against SARS-CoV-2 infection can occur as early as one-week post-symptom onset, and IgM, IgG, and IgA antibody production has been documented at early stages of infection, possibly via the extrafollicular pathway (Woodruff et al., 2020; Lee et al., 2022). This evidence concerns the gene CD40LG and infection.